Company / Capital Expenditures
Twist Bioscience Corp Capital Expenditures History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$28.0M
FY2025
5-year range
$5.1M / $101.9M
FY2021-FY2025
Trend
+451.7%
vs FY2024
Sector context
#37 of 192
Health Care
What the data says
Capital Expenditures changed +452% YoY in FY2025, a notable deviation from the 8-year average annual change of +121%.
Based on SEC 10-K filings.
$28M in FY2025 with a 5-year CAGR of +23.2%. Top quartile in the Health Care sector.
Remained stable around $28M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -35.0%
- 5-Year CAGR
- +23.2%
- 10-Year CAGR
- -
Sector benchmark
Top 19% in Health CareTop 19% of 192This company $28.0M Sector average $118.6M
▼
-76.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +23.2%, indicating consistent growth.
- In FY2025, capital expenditures increased 451.7% year-over-year.
- Ranks #37 out of 192 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $28.0M | +451.7% |
| FY2024 | $5.1M | -81.7% |
| FY2023 | $27.8M | -72.7% |
| FY2022 | $101.9M | +276.4% |
| FY2021 | $27.1M | +174.2% |
| FY2020 | $9.9M | -33.1% |
| FY2019 | $14.8M | +300.1% |
| FY2018 | $3.7M | -44.1% |
| FY2017 | $6.6M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026